martes, 30 de julio de 2013

Neumonia aguda comunitaria: historia, mitologia y ciencia

Este articulo, recientemente publicado, me pareció una buena revision sobre distintos temas en relación a NAC: momento de iniciar tratamiento, por cuanto tiempo, rol de biomarcadores....
Adjunto link:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3715915/pdf/tacca1240000283.pdf


TRANSACTIONS OF THE AMERICAN CLINICAL AND CLIMATOLOGICAL ASSOCIATION, VOL. 124, 2013
COMMUNITY-ACQUIRED PNEUMONIA: 2012 HISTORY, MYTHOLOGY, AND SCIENCE
GERALD R. DONOWITZ, MD CHARLOTTESVILLE, VIRGINIA
ABSTRACT
Pneumonia remains one of the major disease entities practicing physi- cians must manage. It is a leading cause of infection-related morbidity and mortality in all age groups, and a leading cause of death in those older than 65 years of age. Despite its frequency and importance, clinical ques- tions have remained in the therapy of community-acquired pneumonia including when to start antibiotics, when to stop them, who to treat, and what agents to use. Answers to these questions have involved historical practice, mythology, and science—sometimes good science, and sometimes better science. How clinical decisions are made for patients with commu- nity-acquired pneumonia serves as an illustrative model for other problem areas of medicine and allows for insight as to how clinical decisions have been made and clinical practice established. 

No hay comentarios:

Publicar un comentario